Literature DB >> 27993908

Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.

Harsh Golwala1, Navkaranbir Singh Bajaj1, Garima Arora1, Pankaj Arora2.   

Abstract

Entities:  

Keywords:  arrhythmias, cardiac; cardiomyopathies; defibrillators, implantable

Mesh：

Year:  2016        PMID： 27993908      PMCID： PMC5416382          DOI： 10.1161/CIRCULATIONAHA.116.026056

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.

Authors:  Akshay S Desai; James C Fang; William H Maisel; Kenneth L Baughman
Journal:  JAMA       Date:  2004-12-15       Impact factor: 56.272

2.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney
Journal:  Circulation       Date:  2012-12-19       Impact factor: 29.690

3.  Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.

Authors:  Kumaraswamy Nanthakumar; Andrew E Epstein; G Neal Kay; Vance J Plumb; Douglas S Lee
Journal:  J Am Coll Cardiol       Date:  2004-12-07       Impact factor: 24.094

4.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

Authors:  G M Felker; R E Thompson; J M Hare; R H Hruban; D E Clemetson; D L Howard; K L Baughman; E K Kasper
Journal:  N Engl J Med       Date:  2000-04-13       Impact factor: 91.245

5.  Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.

Authors:  Lars Køber; Jens J Thune; Jens C Nielsen; Jens Haarbo; Lars Videbæk; Eva Korup; Gunnar Jensen; Per Hildebrandt; Flemming H Steffensen; Niels E Bruun; Hans Eiskjær; Axel Brandes; Anna M Thøgersen; Finn Gustafsson; Kenneth Egstrup; Regitze Videbæk; Christian Hassager; Jesper H Svendsen; Dan E Høfsten; Christian Torp-Pedersen; Steen Pehrson
Journal:  N Engl J Med       Date:  2016-08-27       Impact factor: 91.245
  5 in total
  25 in total

1.  Response by Golwala et al to Letter Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".

Authors:  Harsh Golwala; Navkaranbir Singh Bajaj; Garima Arora; Pankaj Arora
Journal:  Circulation       Date:  2017-06-20       Impact factor: 29.690

Review 2.  Do We Need an Implantable Cardioverter-defibrillator for Primary Prevention in Cardiac Resynchronisation Therapy Patients?

Authors:  Demosthenes G Katritsis; Angelo Auricchio
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

3.  Meta-analyses: How to critically appraise them?

Authors:  Nirav Patel; Navkaranbir S Bajaj
Journal:  J Nucl Cardiol       Date:  2017-04-26       Impact factor: 5.952

4.  Myocardial recovery after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.

Authors:  Norman C Wang; Aliza Hussain; Evan C Adelstein; Andrew D Althouse; Michael S Sharbaugh; Sandeep K Jain; Alaa A Shalaby; Andrew H Voigt; Samir Saba
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-09-28       Impact factor: 1.468

Review 5.  Should Primary Prevention ICDs Still Be Placed in Patients with Non-ischemic Cardiomyopathy? A Review of the Evidence.

Authors:  Harsha V Ganga; Abhishek Maan; E Kevin Heist
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

Review 6.  Primary prevention implantable cardioverter-defibrillator and opportunities for sudden cardiac death risk assessment in non-ischaemic cardiomyopathy.

Authors:  Rajeev K Pathak; Prashanthan Sanders; Rajat Deo
Journal:  Eur Heart J       Date:  2018-08-14       Impact factor: 29.983

7.  Predicting Arrhythmia Risk in Dilated Cardiomyopathy Using Genetic Mutation Status.

Authors:  Elizabeth M McNally; Ansel Philip Amaral
Journal:  J Am Coll Cardiol       Date:  2019-09-17       Impact factor: 24.094

8.  Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.

Authors:  Sana M Al-Khatib; Gregg C Fonarow; Jose A Joglar; Lurdes Y T Inoue; Daniel B Mark; Kerry L Lee; Alan Kadish; Gust Bardy; Gillian D Sanders
Journal:  JAMA Cardiol       Date:  2017-06-01       Impact factor: 14.676

9.  Sex-specific clinical outcomes after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.

Authors:  Norman C Wang; Ure Mezu-Chukwu; Evan C Adelstein; Andrew D Althouse; Michael S Sharbaugh; Sandeep K Jain; Alaa A Shalaby; Andrew H Voigt; Samir Saba
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-03-27       Impact factor: 1.468

Review 10.  Who Should Receive a Wearable Defibrillator Vest at Hospital Discharge?

Authors:  Sergey Kachur; Daniel P Morin
Journal:  Curr Cardiol Rep       Date:  2019-09-07       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.